Medical Science Liaison
in health
What a Medical Science Liaison does across UK pharma biotech and diagnostics plus the skills employers test and honest salary bands by level.
A Medical Science Liaison (MSL) is the scientific and clinical voice of a company to the doctors, pharmacists, nurses and researchers who treat patients and run trials. They sit inside Medical Affairs, deliberately kept apart from sales, and their job is honest scientific exchange about a medicine, device or diagnostic: explaining the evidence, answering hard clinical questions, and carrying what they hear in the field back into the company's decisions. In plain terms, an MSL exists so the company's clinical story stays accurate and balanced for the people who rely on it, and so the evidence strategy stays anchored in patient impact rather than internal optimism.
You will find MSLs across UK health and life sciences: pharma and biotech (the largest employers by far), medical device makers, diagnostics and genomics firms, contract research organisations (CROs), and digital health scale-ups whose software sits close to clinical decisions. The therapy area shapes the day more than the sector label does. An oncology MSL at a large pharma company and a rare-disease MSL at a small biotech are doing the same job: building credibility with key opinion leaders, presenting trial data without overstating it, and feeding real-world signals back to R&D and medical leadership.
The role exists because these products sit close to clinical decision-making, patient safety and the ABPI Code. That creates a constant need for credible non-promotional conversation, careful handling of unsolicited medical questions, and disciplined reading of clinical evidence. The MSL owns the quality of those interactions: what is said externally, how questions are answered, how field insight is captured, and when something must be escalated for safety or regulatory reasons.
How this role differs in health and life sciences
In many commercial roles, strong relationships and product fluency are enough to drive adoption. Here, adoption is constrained by clinical risk, governance and accountability that do not bend just because a product is good. An MSL earns trust through the quality of the evidence, transparency about its limits, and consistent alignment with appropriate use, never through persuasion. The line between scientific exchange and promotion is not a nicety: cross it and you breach the ABPI Code, which can cost the company access and reputation.
The setting changes the texture of the work. At a large pharma company the therapy area is mature and the data set is deep, so the MSL competes on the precision of the conversation. At an early biotech or a diagnostics firm the evidence is younger, the questions are sharper, and the MSL has to be candid about what is not yet known while still being useful. In digital health and medical devices, questions about model performance, patient cohorts and real-world workflow can become clinical-safety questions quickly, and the MSL is often the person expected to hold those threads in a way clinicians recognise as rigorous.
Pace against risk is the constant tension. The pipeline moves and a launch has a date, so the MSL has to make sure the external scientific story never gets ahead of the evidence, that learning loops are structured rather than anecdotal, and that field feedback reaches the right teams without blurring the boundary between exchange and promotion.
Core responsibilities of a Medical Science Liaison
Day to day, an MSL is the company's credible scientific counterpart to external experts. The work is field-based and judgement-heavy, and the best MSLs know the clinical context as well as the product: how the care pathway actually runs, what good outcomes look like, and where the product might add friction or risk.
- Build and sustain peer relationships with KOLs, investigators and treating clinicians grounded in scientific credibility rather than commercial favour.
- Present and discuss clinical and real-world evidence accurately, stating clearly what the data can and cannot support.
- Respond to unsolicited medical and scientific questions, deciding what to answer directly, what to route to Medical Information, and what requires escalation.
- Capture structured field insight on unmet need, evidence gaps and real-world use, then translate it into actionable input for R&D, clinical, regulatory and leadership teams.
- Support clinical study activity: identifying and engaging sites, supporting investigators, and helping trial data be understood correctly.
- Plan and run advisory boards and scientific meetings that gather expert input on the evidence base and the pipeline.
- Hold the ABPI Code line under commercial pressure, knowing when to say no and when to escalate a compliance, safety or pharmacovigilance concern.
The harder part is the judgement under constraint. When an influential clinician challenges the evidence, the MSL decides what can be answered now, what needs escalation, and how to stay helpful without over-claiming. When the field signals a gap between how a product was designed and how it is used, the MSL turns that into insight without inflating a single anecdote into truth, and without diluting a genuine safety concern.
Skills and competencies for a Medical Science Liaison
| Core skill | What it looks like in health and life sciences | Why it matters |
|---|---|---|
| Scientific judgement | Reading clinical and real-world evidence with clear boundaries on what can and cannot be concluded, across mature and early-stage data | Prevents over-claiming, protects patients, and keeps credibility when the evidence is early, mixed or context-dependent |
| Therapy area depth | Genuine command of the disease area, the competitive data set and the guidelines (NICE, treatment pathways) you are discussing | KOLs are specialists and will test you; shallow knowledge ends the relationship |
| Non-promotional discipline | Comfort holding a scientific line under commercial urgency, and fluency in the ABPI Code boundary between exchange and promotion | Keeps the company compliant and protects access; a Code breach is expensive and public |
| KOL relationship-building | Peer-to-peer engagement that works with clinicians and researchers trained to challenge assumptions | Drives durable trust and turns the field into a real insight channel, not a one-way broadcast |
| Field insight to action | Turning scattered field signals into structured input that R&D, clinical and regulatory teams can act on | Ensures external reality shapes internal priorities, especially when evidence work is slow or costly |
| Escalation instinct | Clear thresholds for when a question becomes a safety, pharmacovigilance or governance matter, and how to route it fast | Cuts time to mitigation and stops small signals becoming serious incidents |
Most MSL roles ask for an advanced degree (PhD, PharmD, MD or a strong life-sciences MSc) plus deep therapy-area knowledge. A clinical or pharmacy background helps, though it is the scientific credibility and the communication that win the job.
Salary ranges for a Medical Science Liaison in the UK
MSL pay tracks therapy area, employer type and field scope more than years alone. Specialist areas such as oncology, rare disease and cell and gene therapy pay at the top of each band, and big pharma generally pays above early-stage biotech and CROs on base, though biotech and scale-ups often add equity. London, Cambridge and Oxford carry a premium for cost of living and competition for talent. Most MSL roles are field-based with a car or car allowance rather than office-bound.
| Experience level | Estimated annual base salary | What drives the number |
|---|---|---|
| Junior (Associate MSL) | London & South East: £45,000 to £58,000. Rest of UK: £40,000 to £52,000 | Narrower portfolio, closer supervision, building independence in handling enquiries and KOL conversations |
| Mid-level (2 to 5 years) | London & South East: £58,000 to £78,000. Rest of UK: £55,000 to £72,000 | Owning a territory and KOL plan, consistent insight quality, operating independently on evidence discussions |
| Senior (5+ years) | London & South East: £78,000 to £95,000. Rest of UK: £72,000 to £90,000 | High-value KOL networks, complex evidence conversations, influence on evidence strategy, often a launch or specialist therapy area |
| Lead (MSL Manager) | London & South East: £95,000 to £120,000. Rest of UK: £88,000 to £110,000 | Leading a field medical team, accountability for standards and planning, multi-product or national scope |
| Head / Director (Medical Affairs) | London & South East: £120,000 to £165,000. Rest of UK: £110,000 to £150,000 | Strategic ownership of medical affairs, governance, scientific reputation and the operating model; reflects organisational risk and scale |
Sources: biotechnologyjobs.co.uk UK MSL guide (2025), Reed and Indeed UK live listings, Glassdoor UK (pharma employers), and UK medical affairs career guides. Treat these as a guide; real offers move with employer, setting and specialism.
Beyond base, total reward usually includes a bonus tied to company and functional objectives rather than sales, a company car or car allowance for the travel, plus pension and private healthcare. Equity or long-term incentives show up more often in venture-backed biotech and scale-ups, especially at Lead and Director level.
Career pathways
Most MSLs arrive from a scientific or clinical career where evidence interpretation and peer communication are already central: a PhD or PharmD, hospital pharmacy, nursing, clinical research (CRA or trial roles), or medical writing and medical information. The common thread is therapy-area depth and the credibility to hold a scientific conversation with a consultant who knows the data.
Progression tracks ownership. Early on it is about answering enquiries accurately and building genuine KOL relationships. As you grow, you own a territory strategy: which experts matter, what insight the business needs, and how scientific engagement supports safe and appropriate use. Senior progression is less about being more technical and more about being trusted with launches, messier evidence questions and the moments where the right call is to slow down, generate more data, or change course.
From there the path forks. Lead and Director routes move into operating-model design: setting standards for scientific exchange, coaching MSLs, shaping evidence strategy and protecting credibility when growth pressure collides with the evidence. Others move sideways into Medical Information, medical strategy, market access or clinical development, all of which value the field perspective an MSL builds.
FAQ
Do you need to be a doctor to become an MSL?
No. An MD helps in some therapy areas, but a PhD, PharmD or a strong life-sciences MSc with deep therapy-area knowledge is the common route. What is non-negotiable is the scientific credibility to engage specialists as a peer.
Do MSL interviews test product knowledge or clinical judgement?
Both, and judgement usually carries more weight. Expect a scientific presentation on a clinical paper plus scenario questions: how you would handle a KOL challenging your data, an unsolicited off-label question, or internal pressure to simplify the story. Strong candidates show boundaries, escalation instinct and balanced communication.
How do I move into an MSL role from a commercial or sales-facing job?
Show independence through real examples: how you handled uncertainty, corrected a misconception, or put patient impact ahead of persuasion. Hiring teams look for people who build trust by being transparent about limitations, and who understand the ABPI Code boundary, not people who win the conversation.
Is the job office-based or field-based?
Mostly field-based. You travel to see clinicians and attend congresses, usually with a company car or car allowance, and work from home between visits. Coverage size and travel expectations vary by employer and therapy area, so ask early.
Find your next role
If you are ready to build credibility at the meeting point of evidence, product and patient impact, search Medical Science Liaison roles on Meeveem.